Myomectomy; Surgical Blood Loss

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Myomectomy; Surgical Blood Loss trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingNot Applicable

NCT07352761

Bilateral Uterine Artery Occlusion During Laparoscopic Myomectomy

The current study is a multiple-arm, single blinded, and controlled randomized trial. It will be conducted in two gynecological endoscopy centers: • ElShatby Un…

Egypt60 participantsStarted 2025-05-01

Treatment: Temporary clipping of uterine artery, Temporary occlusive suturing of uterine artery

RecruitingNot Applicable

NCT06882824

Prevention of HEMOrhagic Risk in Upper MYOmeCTomy by Use of Misoprostol.

In France, uterine fibroids or leiomyomas are the most common benign tumour in women of childbearing age. In 30% of cases, fibroids are symptomatic (menorrhagi…

France80 participantsStarted 2025-03-12

Treatment: myomectomy with placebo, myomectomy with misoprostol

All recent trials (19 shown)

CompletedNot Applicable

NCT07553091

Bleeding Control Methods in Open Myomectomy

Excessive intraoperative bleeding remains a major challenge during open myomectomy and may lead to postoperative anemia and increased morbidity. Numerous method…

Turkey (Türkiye)120 participantsStarted 2024-12-15

Treatment: Tourniquet application, Uterine artery bulldog clamp

WithdrawnPhase 4

NCT05538689

Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL)

In this project, the proposition is that the use of daily dosed Myfembree ( a combination of relugolix with estradiol and norethindrone acetate), FDA-approved m…

United States0Started 2022-11-20

Treatment: Myfembree Oral Product

Myomectomy; Surgical Blood Loss

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Bilateral Uterine Artery Occlusion During Laparoscopic Myomectomy

Prevention of HEMOrhagic Risk in Upper MYOmeCTomy by Use of Misoprostol.

All recent trials (19 shown)

Bleeding Control Methods in Open Myomectomy

Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL)

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Bilateral Uterine Artery Occlusion During Laparoscopic Myomectomy

Prevention of HEMOrhagic Risk in Upper MYOmeCTomy by Use of Misoprostol.

All recent trials (19 shown)

Bleeding Control Methods in Open Myomectomy

Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL)

Impact of Uterine and Ovarian Vessel Occlusion on Blood Loss in High Burden Minimally Invasive Myomectomy.

Rectal Misoprostol as a Hemostatic Agent During Abdominal Myomectomy

Comparison Effectiveness of Rectal Misoprostol & Intravenous Tranexamic Acid Reducing Hemorrhage in Myomectomy

Misoprostol for Reduction of Blood Loss During Fibroid Surgery

Methods Decreasing Bleeding in Open Myomectomy

Effect of Rectal Misoprostol in Reducing Intra-operative Blood Loss During Myomectomy

ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma

Mode of Action Study of Vilaprisan and Ulipristal Acetate in Patients With Uterine Fibroids for Whom Surgery is Planned

Vasopressin Injection Versus Misoprostol During Hysteroscopic Myomectomy In Reducing Blood Loss And Operation Time.

Single or Triple Uterine Tourniquet at Myomectomy

the Effect of Misoprostol on Intra-operative Blood Loss During Myomectomy Operation

Vasopressin Administration During Laparoscopic Myomectomy: a Randomized Controlled Trial

Hemostatic Effect of Intrauterine Instillation Of Tranexamic Acid In Hysteroscopic Myomectomy

Intravenous Tranexamic Acid Versus Pericervical Tourniquet To Decrease Blood Loss In Trans-Abdominal Myomectomy

Impact of Misoprostol on Blood Loss In Myomectomy Operations